Statistics for A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
Total visits
views | |
---|---|
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium | 0 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:4c779db0-505f-46c5-8a75-5bbc794933e3 | 22 |
java.util.UUID:358990a4-e9c6-4d72-a575-d3842cfe29b8 | 10 |
Jackson2022Phase-AAM.pdf | 6 |
java.util.UUID:0d888d78-e8cf-466f-92ac-84ec3b2a1953 | 3 |